Home > H3D News > News

News

Current news articles are found here.

Strengthening Capacity for Drug Discovery Research in Africa
Fri, 15 Mar 2019 - 14:00
Course gives comprehensive overview of the drug discovery process with special focus on international and inter-disciplinary collaboration.

In April 2019 Advanced Courses and Scientific Conferences (ACSC) held a one-week course in South Africa entitled ‘Practical Aspects of Drug Discovery: At the Interface of Biology, Chemistry and Pharmacology’.

 

Drug Discovery in Africa
Fri, 15 Mar 2019 - 14:00

REGISTER NOW!

June 5, 2019

http://bit.ly/VKSafricadrugdiscovery 

#VKSafricadrugdiscovery

Kelly Chibale in the Financial Times
Fri, 15 Mar 2019 - 14:00

The US Financial Times recently featured Kelly Chibale as an Innovator in Drug Discovery in Africa

 

KELLY CHIBALE: LEADING THE WAY IN AFRICAN DRUG DISCOVERY
Mon, 11 Mar 2019 - 14:00

KELLY CHIBALE: LEADING THE WAY IN AFRICAN DRUG DISCOVERY

The rag in Kelly Chibale’s rags-to-riches story is the lit one he used to put into a paraffin-filled tub so that he could study at night. Brought up amid violence and squalor in the Zambian copper belt settlement of Kabulanda — whose name, he says, literally denotes “sadness” — Mr Chibale has fashioned a successful career from a tough start.

GOLD MEDALLIST CHIBALE WARNS OF AFRICAN 'BRAIN DRAIN'
Wed, 24 Oct 2018 - 14:00

UCT’S H3D DIRECTOR, KELLY CHIBALE, WINS SACI GOLD MEDAL AWARD AND IS HONOURED BY ASTMH; WARNS ABOUT THE BRAIN DRAIN OF AFRICAN SCIENTISTS

Professor Kelly Chibale, founder and director of the Drug Discovery and Development Centre, H3D, at the University of Cape Town (UCT), has been awarded the prestigious Gold Medal for 2018 by the South African Chemical Institute (SACI) and honoured by the American Society of Tropical Medicine and Hygiene (ASTMH) with the 2018 Commemorative Fund Lecture.  

GRAND CHALLENGES MEETING
Wed, 24 Oct 2018 - 14:00

Prof Kelly Chibale participated in the Bill and Melinda Gates Foundation's Grand Challenges meeting held in Berlin, Germany from 15-18 October 2018 and gave a Spotlight talk.  

PRACTICAL ASPECTS OF DRUG DISCOVERY
Fri, 29 Jun 2018 - 14:00
Learn about the theoretical, practical and organisational aspects of small molecule and natural product drug discovery.
UCT KEY IN NEW DRUGS SEARCH
Fri, 29 Jun 2018 - 14:00
The University of Cape Town’s Drug Discovery and Development Centre (H3D) will be pivotal in a new international drug discovery programme aimed at financing not only the identification of new drug candidates to combat diseases such as malaria and tuberculosis, but also the development of African scientists.
OPEN CALL FOR LETTER OF INTENT (LOI) ON DRUG DISCOVERY
Mon, 23 Apr 2018 - 14:00
1. Background

Drug discovery excellence is a critical prerequisite for success in drug development and remains a highly neglected area for the African continent. The lack of market incentives has biased drug discovery efforts globally away from diseases most prevalent in the developing world. Collaborative efforts of multidisciplinary teams – in drug discovery and other fields – shows that success and efficiency increases significantly when individual contributors combine their complementary capabilities. The whole is greater than the sum of its parts. State-of-the-art approaches to implementing drug discovery projects, especially when the goal is to also build drug discovery capability on the African continent, need to be supported.

PIONEER OF WORLD CLASS DRUG DISCOVERY CENTRE IN AFRICA IS NAMED ONE OF FORTUNE’S 50 WORLD’S GREATEST LEADERS FOR 2018
Mon, 23 Apr 2018 - 14:00

The founder and director of Africa’s first integrated drug discovery centre, Professor Kelly Chibale, has been named as one of Fortune magazine’s World’s Greatest Leaders for 2018.

Chibale, whose H3D centre at the University of Cape Town pioneers world-class drug discovery in Africa, has also become known for his pivotal work on malaria.

THE WORLD'S 50 GREATEST LEADERS
Thu, 19 Apr 2018 - 18:00

45. Kelly Chibale

Scientist, South Africa

In much of Africa, the infrastructure to support scientific research is sorely lacking. But Chibale is working to change that. The Zambian chemist has built H3D, Africa’s first integrated drug discovery center, at the University of Cape Town. His team now includes more than 90 researchers; they work out of state-of-the-art facilities thanks to partnerships with the Gates Foundation, Novartis, and South Africa’s government. H3D already has a potential drug for ­malaria in human trials.

Project team
MERCK, UNIVERSITY OF CAPE TOWN AND MEDICINES FOR MALARIA VENTURE JOIN FORCES TO FEED THE ANTIMALARIAL PIPELINE
Thu, 19 Apr 2018 - 15:00
Merck, the University of Cape Town and Medicines for Malaria Venture create an antimalarial drug discovery platform, strengthening their partnership in the fight against malaria The partners will collaborate to build research capacity in Africa

Pages